Effect of Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis
Author(s) -
Heather Hsu,
Kathleen A. Shutt,
Matthew R. Moore,
Bernard Beall,
Nancy M. Bennett,
Allen S. Craig,
Monica M. Farley,
James H. Jorgensen,
Catherine Lexau,
Susan Petit,
Arthur Reingold,
William Schaffner,
Ann Thomas,
Cynthia G. Whitney,
Lee H. Harrison
Publication year - 2009
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa0800836
Subject(s) - medicine , meningitis , pneumococcal conjugate vaccine , pneumococcal infections , streptococcus pneumoniae , bacterial meningitis , pneumococcal vaccine , pediatrics , virology , antibiotics , microbiology and biotechnology , biology
Invasive pneumococcal disease declined among children and adults after the introduction of the pediatric heptavalent pneumococcal conjugate vaccine (PCV7) in 2000, but its effect on pneumococcal meningitis is unclear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom